• 1. Department of Ophthalmology, Jiangmen Central Hospital, Affiliated to Guangdong Medical University, Jiangmen 529000, China;
  • 2. Department of Ophthalmology, People’s Hospital of Jiangmen, Jiangmen 529000, China;
Peng Chao, Email: ppy1125@126.com
Export PDF Favorites Scan Get Citation

Choroidal vascularity index (CVI), as a new biological parameter to quantitatively evaluate the state of choroidal vessels, has shown great potential in the diagnosis and treatment of ophthalmic diseases in recent years. CVI primarily calculated from images obtained via optical coherence tomography (OCT) and OCT angiography, demonstrates enhanced accuracy, stability, and clinical value with the advancement of three-dimensional imaging and artificial intelligence technologies. Compared with two-dimensional CVI, three-dimensional CVI comprehensively reflects the spatial distribution and structural changes of choroidal blood vessels by constructing three-dimensional choroidal models through ultra-widefield scanning. In various ophthalmic diseases, including age-related macular degeneration, central serous chorioretinopathy, diabetic retinopathy, and pathological myopia, CVI exhibits characteristic changes that not only contribute to understanding disease pathogenesis but also serve as indicators for early screening, individualized treatment, and efficacy monitoring. The application of artificial intelligence and deep learning technology improves the efficiency of automated CVI analysis, while integration with multimodal imaging further optimizes disease evaluation. Future efforts should focus on establishing standardized measurement protocols and quality control systems to promote its broader application and development in ophthalmology.

Copyright © the editorial department of Chinese Journal of Ocular Fundus Diseases of West China Medical Publisher. All rights reserved